These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 23573967)
1. Challenges and opportunities in tuberculosis drug discovery: an industry perspective. Shirude PS; Ramachandran S; Hosagrahara V Future Med Chem; 2013 Apr; 5(5):499-501. PubMed ID: 23573967 [No Abstract] [Full Text] [Related]
2. Welcome to 'Tuberculosis drug discovery and development'. D'Oca G Future Med Chem; 2010 Aug; 2(8):1241-2. PubMed ID: 21426014 [No Abstract] [Full Text] [Related]
3. Current challenges in drug discovery for tuberculosis. Kumar A; Chettiar S; Parish T Expert Opin Drug Discov; 2017 Jan; 12(1):1-4. PubMed ID: 27797593 [No Abstract] [Full Text] [Related]
4. Perspective: Challenges and opportunities in TB drug discovery from phenotypic screening. Manjunatha UH; Smith PW Bioorg Med Chem; 2015 Aug; 23(16):5087-97. PubMed ID: 25577708 [TBL] [Abstract][Full Text] [Related]
6. Hollow Fiber System Model for Tuberculosis: The European Medicines Agency Experience. Cavaleri M; Manolis E Clin Infect Dis; 2015 Aug; 61 Suppl 1():S1-4. PubMed ID: 26224766 [TBL] [Abstract][Full Text] [Related]
7. High-content imaging of Mycobacterium tuberculosis-infected macrophages: an in vitro model for tuberculosis drug discovery. Christophe T; Ewann F; Jeon HK; Cechetto J; Brodin P Future Med Chem; 2010 Aug; 2(8):1283-93. PubMed ID: 21426019 [TBL] [Abstract][Full Text] [Related]
8. Structural genomics approach to drug discovery for Mycobacterium tuberculosis. Ioerger TR; Sacchettini JC Curr Opin Microbiol; 2009 Jun; 12(3):318-25. PubMed ID: 19481971 [TBL] [Abstract][Full Text] [Related]
9. Improving the tuberculosis drug development pipeline. Evangelopoulos D; McHugh TD Chem Biol Drug Des; 2015 Nov; 86(5):951-60. PubMed ID: 25772393 [TBL] [Abstract][Full Text] [Related]
10. Informatics resources for tuberculosis--towards drug discovery. Sundaramurthi JC; Brindha S; Reddy TB; Hanna LE Tuberculosis (Edinb); 2012 Mar; 92(2):133-8. PubMed ID: 21943870 [TBL] [Abstract][Full Text] [Related]
11. Current Affairs, Future Perspectives of Tuberculosis and Antitubercular Agents. Gawad J; Bonde C Indian J Tuberc; 2018 Jan; 65(1):15-22. PubMed ID: 29332642 [TBL] [Abstract][Full Text] [Related]
13. In silico analyses for the discovery of tuberculosis drug targets. Chung BK; Dick T; Lee DY J Antimicrob Chemother; 2013 Dec; 68(12):2701-9. PubMed ID: 23838951 [TBL] [Abstract][Full Text] [Related]
14. New tuberculosis drugs on the horizon. Cole ST; Riccardi G Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466 [TBL] [Abstract][Full Text] [Related]
15. Challenges and opportunities in developing novel drugs for TB. Kaneko T; Cooper C; Mdluli K Future Med Chem; 2011 Sep; 3(11):1373-400. PubMed ID: 21879843 [TBL] [Abstract][Full Text] [Related]
16. Emerging drugs for active tuberculosis. Ginsberg AM Semin Respir Crit Care Med; 2008 Oct; 29(5):552-9. PubMed ID: 18810688 [TBL] [Abstract][Full Text] [Related]
17. The relevance of persisters in tuberculosis drug discovery. Mandal S; Njikan S; Kumar A; Early JV; Parish T Microbiology (Reading); 2019 May; 165(5):492-499. PubMed ID: 30775961 [TBL] [Abstract][Full Text] [Related]
18. [Discrepancy between drug resistance of mycobacterium tuberculosis determined in vitro and in vivo]. Belogurova VP; Gorislavets II; Ivanitskaia NN Probl Tuberk; 1971; 49(6):76-80. PubMed ID: 5000746 [No Abstract] [Full Text] [Related]